Cargando…
Drug Discovery of New Anti-Inflammatory Compounds by Targeting Cyclooxygenases
The goal of achieving anti-inflammatory efficacy with the fewest possible adverse effects through selective COX-2 inhibition is still being investigated in order to develop drugs with safe profiles. This work shows the efficacy and safety profile of two novel benzimidazole piperidine and phenoxy pyr...
Autores principales: | Burayk, Shady, Oh-hashi, Kentaro, Kandeel, Mahmoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955829/ https://www.ncbi.nlm.nih.gov/pubmed/35337080 http://dx.doi.org/10.3390/ph15030282 |
Ejemplares similares
-
Discovery of New Potent anti-MERS CoV Fusion Inhibitors
por: Kandeel, Mahmoud, et al.
Publicado: (2021) -
AICD: an integrated anti-inflammatory compounds database for drug discovery
por: Wang, Kun, et al.
Publicado: (2019) -
Vanadium Compounds as Pro-Inflammatory Agents: Effects on Cyclooxygenases
por: Korbecki, Jan, et al.
Publicado: (2015) -
Study of Osteoarthritis Treatment with Anti-Inflammatory Drugs: Cyclooxygenase-2 Inhibitor and Steroids
por: Cho, Hongsik, et al.
Publicado: (2015) -
Variability of the drug response to nonsteroidal anti-inflammatory drugs according to cyclooxygenase-2 genetic polymorphism
por: Lee, Sook Joung, et al.
Publicado: (2017)